A detailed history of Prentice Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prentice Wealth Management LLC holds 1,162 shares of LLY stock, worth $964,157. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,162
Previous 1,369 15.12%
Holding current value
$964,157
Previous $1.24 Million 16.95%
% of portfolio
0.31%
Previous 0.41%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$772.14 - $960.02 $159,832 - $198,724
-207 Reduced 15.12%
1,162 $1.03 Million
Q2 2024

Jul 11, 2024

SELL
$724.87 - $909.04 $50,740 - $63,632
-70 Reduced 4.86%
1,369 $1.24 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $20,727 - $27,729
35 Added 2.49%
1,439 $1.12 Million
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $23,108 - $27,241
44 Added 3.24%
1,404 $818,000
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $434 - $599
-1 Reduced 0.07%
1,360 $730,000
Q2 2023

Jul 06, 2023

SELL
$350.74 - $468.98 $54,364 - $72,691
-155 Reduced 10.22%
1,361 $638,000
Q1 2023

Apr 14, 2023

SELL
$310.63 - $364.82 $931 - $1,094
-3 Reduced 0.2%
1,516 $520,000
Q4 2022

Jan 18, 2023

BUY
$321.55 - $374.67 $33,441 - $38,965
104 Added 7.35%
1,519 $0
Q3 2022

Oct 19, 2022

BUY
$296.48 - $337.87 $419,519 - $478,086
1,415 New
1,415 $455,000
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $357,889 - $420,214
-1,284 Closed
0 $0
Q1 2022

Oct 31, 2022

SELL
$234.69 - $291.66 $34,734 - $43,165
-148 Reduced 10.46%
1,267 $361,000
Q4 2021

Oct 31, 2022

SELL
$224.85 - $279.04 $34,402 - $42,693
-153 Reduced 10.81%
1,262 $348,000
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $44,415 - $57,450
246 Added 23.7%
1,284 $295,000
Q1 2021

Jun 17, 2021

SELL
$164.32 - $212.72 $31.7 Million - $41 Million
-192,881 Reduced 99.46%
1,038 $194,000
Q1 2021

Jun 08, 2021

BUY
$164.32 - $212.72 $31.9 Million - $41.3 Million
193,919 New
193,919 $194,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Prentice Wealth Management LLC Portfolio

Follow Prentice Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.